AUSTAR, a technology-based pharmaceutical engineering solution provider, has announced that Ceva Animal Health Technology has chosen AUSTAR to provide upstream and downstream bioprocess solutions for its animal cell production line.
It is expected that two bioreactors used for cultivation of insect cell baculovirus, two process inactivation tanks for virus inactivation, drug substance transfer pipelines and automatic control systems, complying with GMP standards, will be delivered in 2024, supporting the client’s animal vaccine batch production.
AUSTAR’s scope of work involves detail design, modular design, fabrication, installation and commissioning.
The design with bottom mounted magnetic agitator will prevent cell culture contamination and the shear force during the cell culture process will be reduced when optimising the impeller, which shows how AUSTAR helps our clients address and solve containment challenges in the cell cultivation field.
AUSTAR and its team will work closely with the client's project team to drive the implementation of the project and deliver high-value, problem-solving and effective solutions and technical support, helping Ceva Animal Health Technology (Hangzhou) achieve its mission.
